Superworth

Stereotaxis EPS STXS

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Jun 30, 2026
−$0.24
Latest quarter, Q2 FY26
−$0.05
Fiscal year 2025
−$0.25

Stereotaxis' earnings per share was −$0.24 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.05.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$0.25n/a
FY2024−$0.30n/a
FY2023−$0.28n/a
FY2022−$0.26n/a
FY2021−$0.16n/a
FY2020−$0.11n/a
FY2019−$0.09n/a
FY2018−$0.04n/a
FY2017−$0.35n/a
FY2016−$0.55n/a
FY2015−$0.35n/a
FY2014−$0.27n/a
FY2013−$5.70n/a
FY2012−$1.54n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.05n/a−$0.24
Q1 FY26−$0.06n/a−$0.24
Q4 FY25−$0.06n/a−$0.25
Q3 FY25−$0.07n/a−$0.28
Q2 FY25−$0.05n/a−$0.29
Q1 FY25−$0.07n/a−$0.31
Q4 FY24−$0.09n/a−$0.30
Q3 FY24−$0.08n/a−$0.28
Q2 FY24−$0.07n/a−$0.27
Q1 FY24−$0.06n/a−$0.27
Q4 FY23−$0.07n/a−$0.28
Q3 FY23−$0.07n/a−$0.27

Against its peers

Companies in Healthcare nearest Stereotaxis' size, closest first, today.

CompanyEPS, 12 monthsGrowth
STXSStereotaxis−$0.24
KEQUKewaunee Scientific$2.76−33% a year
ICCCImmucell$0.08−58% a year
LFVNLifevantage$0.40−46% a year
SPROSpero Therapeutics$0.11
APTAlpha Pro Tech$0.41+24% a year
PDEXPro DEX$4.11+52% a year
PLXProtalix BioTherapeutics$0.23+283% a year
NATRNatures Sunshine Products$1.01+36% a year
ATNMActinium Pharmaceuticals$0.36
ELMDElectromed$1.31+56% a year
Peer median$0.41

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Stereotaxis

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.